SEC Form 4 · accession 0001209191-15-043354
CELGENE CORP /DE/ · CELG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence V Stein
Officer — See Remarks
Period of report
May 14, 2015
Accepted (ET)
May 15, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816284
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 14, 2015 | M | 2,542 | $39.33 | A | 16,591 | D | |
| Common Stock | May 14, 2015 | S | 2,542 | $114.85 | D | 14,049 | D | |
| Common Stock | holding | — | — | — | 519 | I | 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $39.33 | May 14, 2015 | M | 2,542 | D | — | Dec 3, 2022 | Common Stock | 2,542 | 5,084 | D |
Explanation of responses
- F1The option was fully exercisable.
- F2The option was issued pursuant to the Celgene Corporation 2008 Stock Incentive Plan (amended and restated as of April 17, 2013).
Remarks
Executive Vice President, General Counsel and Corporate Secretary